Medical Properties Trust, Inc.

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: US58463J3041
USD
5.61
-0.01 (-0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.38 M

Shareholding (Mar 2025)

FII

10.97%

Held by 191 FIIs

DII

45.94%

Held by 89 DIIs

Promoter

0.00%

How big is Medical Properties Trust, Inc.?

22-Jun-2025

As of Jun 18, Medical Properties Trust, Inc. has a market capitalization of 2,667.55 million, categorizing it as a Small Cap company, with recent net sales of 948.03 million and a net profit of -1,651.98 million.

Market Cap: As of Jun 18, Medical Properties Trust, Inc. has a market capitalization of 2,667.55 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 948.03 million, while the sum of Net Profit is -1,651.98 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the Shareholder's Funds amount to 4,832.73 million, and the Total Assets are 14,294.59 million.

Read More

What does Medical Properties Trust, Inc. do?

22-Jun-2025

Medical Properties Trust, Inc. is a real estate investment trust (REIT) that invests in net-leased healthcare facilities. As of March 2025, it has a market cap of approximately $2.67 billion, a dividend yield of 7.19%, and reported a net profit loss of $118 million.

Overview:<BR>Medical Properties Trust, Inc. is a real estate investment trust (REIT) that focuses on investing in and owning net-leased healthcare facilities, operating within the Realty industry and categorized as a small-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 224 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -118 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 2,667.55 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 7.19% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: -8.48% <BR>Price to Book: 0.56<BR><BR>Contact Details:<BR>Address: 1000 Urban Center Dr Ste 501, BIRMINGHAM AL : 35242 <BR>Tel: 1 205 9693755 <BR>Fax: 1 205 9693756 <BR>Website: http://www.medicalpropertiestrust.com/

Read More

Who are in the management team of Medical Properties Trust, Inc.?

22-Jun-2025

As of March 2022, the management team of Medical Properties Trust, Inc. includes Edward Aldag (Chairman, President, CEO), R. Steven Hamner (CFO, Executive VP, Director), and Michael Stewart (Lead Independent Director), along with Independent Directors G. Steven Dawson, Caterina Mozingo, Elizabeth Pitman, and Daniel Sparks. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Medical Properties Trust, Inc. includes:<BR><BR>- Mr. Edward Aldag, who serves as the Chairman of the Board, President, and Chief Executive Officer.<BR>- Mr. R. Steven Hamner, who is the Chief Financial Officer, Executive Vice President, and a Director.<BR>- Mr. Michael Stewart, serving as the Lead Independent Director.<BR>- Mr. G. Steven Dawson, Ms. Caterina Mozingo, Ms. Elizabeth Pitman, and Mr. Daniel Sparks, all of whom are Independent Directors.<BR><BR>This team is responsible for overseeing the company's strategic direction and operations.

Read More

Is Medical Properties Trust, Inc. overvalued or undervalued?

20-Sep-2025

As of October 26, 2023, Medical Properties Trust, Inc. is considered risky and overvalued due to a low Price to Book Value of 0.57, a high EV to EBITDA ratio of 3.71, a negative ROE of -8.48%, and mixed stock performance, despite a recent 1-week return of 9.33% and year-to-date return of 27.59%.

As of 26 October 2023, the valuation grade for Medical Properties Trust, Inc. has moved from very attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.57 and an EV to EBITDA ratio of 3.71, which suggests that investors are paying a premium relative to its earnings potential. Additionally, the company has a negative ROE of -8.48%, further highlighting its financial struggles.<BR><BR>In comparison to its peers, Medical Properties Trust, Inc. has a notably lower EV to EBITDA ratio than Vornado Realty Trust at 9.8148 and Rithm Capital Corp. at 1.6123, both of which are classified as very attractive. The company's recent stock performance shows a 1-week return of 9.33% and a year-to-date return of 27.59%, significantly outperforming the S&P 500's 12.22% return in the same period, but it has underperformed over the longer term, with a 3-year return of -63.48% compared to the S&P 500's 70.41%. This mixed performance reinforces the notion that the stock is currently overvalued.

Read More

Is Medical Properties Trust, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Medical Properties Trust, Inc. shows a bullish trend overall, despite mixed signals from indicators like the weekly RSI and Dow Theory, and while it has underperformed the S&P 500 recently, it has outperformed year-to-date.

As of 31 October 2025, the technical trend for Medical Properties Trust, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the weekly RSI is bearish, which presents a mixed signal. The KST is bullish on both weekly and monthly time frames, while Bollinger Bands show a mildly bullish trend in both weekly and monthly periods. Dow Theory indicates a mildly bearish stance on the weekly chart, with no trend on the monthly.<BR><BR>In terms of performance, the stock has underperformed the S&P 500 over the 1-week and 1-month periods, with returns of -3.90% and -11.01% respectively, while it has outperformed the index year-to-date with a return of 24.81% compared to the S&P 500's 16.30%. Overall, the current technical stance is bullish, but the mixed indicators suggest caution.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 5.75%

  • Poor long term growth as Operating profit has grown by an annual rate of -25.67%
2

Positive results in Jun 25

3

Risky -

4

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 2,753 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

6.97%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-6.62%

stock-summary
Price to Book

0.57

Revenue and Profits:
Net Sales:
240 Million
(Quarterly Results - Jun 2025)
Net Profit:
-98 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
26.07%
0%
26.07%
6 Months
25.5%
0%
25.5%
1 Year
33.57%
0%
33.57%
2 Years
4.86%
0%
4.86%
3 Years
-56.88%
0%
-56.88%
4 Years
-73.74%
0%
-73.74%
5 Years
-72.71%
0%
-72.71%

Medical Properties Trust, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.89%
EBIT Growth (5y)
-25.67%
EBIT to Interest (avg)
3.99
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
2.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
72.77%
ROCE (avg)
10.48%
ROE (avg)
5.75%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.57
EV to EBIT
17.50
EV to EBITDA
3.71
EV to Capital Employed
0.50
EV to Sales
2.17
PEG Ratio
NA
Dividend Yield
8.56%
ROCE (Latest)
2.87%
ROE (Latest)
-8.48%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 95 Schemes (42.99%)

Foreign Institutions

Held by 191 Foreign Institutions (10.97%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 7.42% vs -3.45% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 16.77% vs 71.37% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "240.40",
          "val2": "223.80",
          "chgp": "7.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "78.30",
          "val2": "144.90",
          "chgp": "-45.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "129.70",
          "val2": "115.80",
          "chgp": "12.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "-79.90",
          "chgp": "98.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-98.30",
          "val2": "-118.10",
          "chgp": "16.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.20%",
          "val2": "358.70%",
          "chgp": "-31.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.19% vs -43.50% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -331.99% vs -161.82% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "995.50",
          "val2": "871.80",
          "chgp": "14.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "284.50",
          "val2": "684.60",
          "chgp": "-58.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "417.80",
          "val2": "411.20",
          "chgp": "1.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,888.80",
          "val2": "-376.60",
          "chgp": "-401.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,409.20",
          "val2": "-557.70",
          "chgp": "-331.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-163.90%",
          "val2": "93.20%",
          "chgp": "-25.71%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
240.40
223.80
7.42%
Operating Profit (PBDIT) excl Other Income
78.30
144.90
-45.96%
Interest
129.70
115.80
12.00%
Exceptional Items
-1.20
-79.90
98.50%
Consolidate Net Profit
-98.30
-118.10
16.77%
Operating Profit Margin (Excl OI)
48.20%
358.70%
-31.05%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.42% vs -3.45% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 16.77% vs 71.37% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
995.50
871.80
14.19%
Operating Profit (PBDIT) excl Other Income
284.50
684.60
-58.44%
Interest
417.80
411.20
1.61%
Exceptional Items
-1,888.80
-376.60
-401.54%
Consolidate Net Profit
-2,409.20
-557.70
-331.99%
Operating Profit Margin (Excl OI)
-163.90%
93.20%
-25.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 14.19% vs -43.50% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -331.99% vs -161.82% in Dec 2023

stock-summaryCompany CV
About Medical Properties Trust, Inc. stock-summary
stock-summary
Medical Properties Trust, Inc.
Realty
Medical Properties Trust, Inc. is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company's segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants. The Company conducts its operations through MPT Operating Partnership, L.P. The Company acquires and develops healthcare facilities, and leases the facilities to healthcare operating companies under long-term net leases. The Company makes mortgage loans to healthcare operators collateralized by their real estate assets. The Company owns hospitals with approximately 390 facilities and approximately 42,000 licensed beds in eight countries and across three continents.
Company Coordinates stock-summary
Company Details
1000 Urban Center Dr Ste 501 , BIRMINGHAM AL : 35242
stock-summary
Tel: 1 205 96937551 205 9693755
stock-summary
Registrar Details